Two coronavirus vaccine candidates are in the clinics and 42 more are in preclinical studies, according to updated data provided by the World Health Organization on March 20.

Three biopharma companies issued updates Monday on their developmental efforts for vaccines to combat the deadly virus, which has so far killed more than 35,000 people and infected about 735,000 more, according to Johns Hopkins University.

IMV On Track For Summer Start

Canadian pharma Imv Inc which announced March 18 its intention to develop a DPX-based vaccine candidate for the new coronavirus, said it has initiated discussions with Health Canada to prepare for a clinical trial application…CLICK for complete article